Background: Pulmonary hypertension (PH) is often found in cystic fibrosis (CF) patients affected by end-stage lung disease but its impact on outcome remains unclear. Pulmonary arterial compliance (PAC) is an important determinant of right ventricle (RV) workload and it is a strong predictor of survival in other forms of PH. The aim of this study is to investigate whether PAC is a predictor of long-term prognosis in a population of CF patients affected by advanced lung disease. Methods: Between 2000 and 2014, 178 patients with CF have been evaluated for lung transplantation in our CF Center. Right heart catheterization (RHC) and follow up data were retrievable and analyzed in 141 of them. PAC was defined as the ratio between stroke volume (SV) and pulse pressure (PP) at heart catheterization. The association of PAC with survival was tested at 4 years and compared to other hemodynamic parameters. Results: PH prevalence was 56.4%. Most patients had mild elevation of pulmonary artery pressure (PAP). No difference in mortality was observed in patients with PH compared to patients with normal PAP (HR 0.95: 95% CI 0.49-1.89, p = 0.89). At receiver operating characteristic curve (ROC) analysis, the optimal prognostic cut-off point of PAC was 1.95 ml/mmHg. An impaired PAC (≤ 1.95 ml/mmHg) was a strong independent predictor of long-term mortality (HR 3.44: 95% CI 1.51-7.85: p = 0.003). Conclusions: Impaired PAC is associated with poor prognosis in CF patients awaiting lung transplantation. Other traditional hemodynamic parameters add no prognostic information.

Hemodynamic predictors of long term survival in end stage cystic fibrosis

Scarsini, Roberto
;
MILANO, ELENA GIULIA;CASTELLANI, CARLO;PESARINI, Gabriele;VASSANELLI, Corrado;RIBICHINI, Flavio Luciano
2016-01-01

Abstract

Background: Pulmonary hypertension (PH) is often found in cystic fibrosis (CF) patients affected by end-stage lung disease but its impact on outcome remains unclear. Pulmonary arterial compliance (PAC) is an important determinant of right ventricle (RV) workload and it is a strong predictor of survival in other forms of PH. The aim of this study is to investigate whether PAC is a predictor of long-term prognosis in a population of CF patients affected by advanced lung disease. Methods: Between 2000 and 2014, 178 patients with CF have been evaluated for lung transplantation in our CF Center. Right heart catheterization (RHC) and follow up data were retrievable and analyzed in 141 of them. PAC was defined as the ratio between stroke volume (SV) and pulse pressure (PP) at heart catheterization. The association of PAC with survival was tested at 4 years and compared to other hemodynamic parameters. Results: PH prevalence was 56.4%. Most patients had mild elevation of pulmonary artery pressure (PAP). No difference in mortality was observed in patients with PH compared to patients with normal PAP (HR 0.95: 95% CI 0.49-1.89, p = 0.89). At receiver operating characteristic curve (ROC) analysis, the optimal prognostic cut-off point of PAC was 1.95 ml/mmHg. An impaired PAC (≤ 1.95 ml/mmHg) was a strong independent predictor of long-term mortality (HR 3.44: 95% CI 1.51-7.85: p = 0.003). Conclusions: Impaired PAC is associated with poor prognosis in CF patients awaiting lung transplantation. Other traditional hemodynamic parameters add no prognostic information.
2016
Cystic fibrosis
Pulmonary arterial compliance
Pulmonary hypertension
Right ventricle function
Adult
Cystic Fibrosis
Disease Progression
Female
Follow-Up Studies
Hemodynamics
Humans
Hypertension, Pulmonary
Incidence
Italy
Male
Prognosis
Retrospective Studies
Severity of Illness Index
Survival Rate
Time Factors
Ventricular Function, Right
Cystic fibrosis; Pulmonary arterial compliance; Pulmonary hypertension; Right ventricle function; Adult; Cystic Fibrosis; Disease Progression; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Pulmonary; Incidence; Italy; Male; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Rate; Time Factors; Ventricular Function, Right
File in questo prodotto:
File Dimensione Formato  
Hemodynamic predictors.pdf

non disponibili

Tipologia: Documento in Pre-print
Licenza: Accesso ristretto
Dimensione 393.61 kB
Formato Adobe PDF
393.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Publication9_Scarsini_Hemodynamic predictor of long term survival in end stage cystic fibrosis.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 529.69 kB
Formato Adobe PDF
529.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/958367
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
social impact